Jiso Ryu
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 7
-
- Antibiotic Use and Resistance 3
- Endocrinology top 5%
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 3
-
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Pneumonia and Respiratory Infections 6
-
- Antimicrobial Resistance in Staphylococcus 5
- Antifungal resistance and susceptibility 3
-
- Neutropenia and Cancer Infections 3
Jiso Ryu
19 papers receiving 583 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 312
- Applied Microbiology and Biotechnology 107
- Endocrinology 101
- Clinical Biochemistry 88
- Critical Care and Intensive Care Medicine 50
Countries citing papers authored by Jiso Ryu
This map shows the geographic impact of Jiso Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiso Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiso Ryu more than expected).
Fields of papers citing papers by Jiso Ryu
This network shows the impact of papers produced by Jiso Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiso Ryu. The network helps show where Jiso Ryu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiso Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | In vitro antimicrobial activity of cefditoren against Streptococcus pneumoniae and Haemophilus influenzae clinical isolates | 2007 | 0 |
| 2 | 2006 | 21 | |
| 3 | 2006 | 8 | |
| 4 | In vitro Antimicrobial Activity of Cefcapene against Clinical Isolates | 2005 | 2 |
| 5 | 2005 | 52 | |
| 6 | 2005 | 81 | |
| 7 | 2005 | 3 | |
| 8 | 2005 | 3 | |
| 9 | A Case of Septicemia and Septic Pneumonia due to Burkholderia pseudomallei | 2004 | 6 |
| 10 | 2004 | 1 | |
| 11 | Clinical Efficacy and Safety with Arbekacin for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections | 2003 | 4 |
| 12 | 2003 | 66 | |
| 13 | 2003 | 84 | |
| 14 | 2003 | 10 | |
| 15 | 2003 | 148 | |
| 16 | 2002 | 53 | |
| 17 | 2002 | 28 | |
| 18 | 2001 | 7 | |
| 19 | A Prospective Multicenter Study of Community-acquired Pneumonia in Adults with Emphasis on Bacterial Etiology | 2001 | 22 |
| 20 | 2000 | 9 |
About Jiso Ryu
Jiso Ryu is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 20 papers that have together received 608 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Resistance in Bacteria (7 papers), Pneumonia and Respiratory Infections (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Identification and Susceptibility Testing (3 papers), Neutropenia and Cancer Infections (3 papers), Antifungal resistance and susceptibility (3 papers) and Antibiotic Use and Resistance (3 papers). The work is most often cited by research in Molecular Medicine (312 citations), Applied Microbiology and Biotechnology (107 citations) and Endocrinology (101 citations). Jiso Ryu has collaborated with scholars based in South Korea and Belgium. Frequent co-authors include Yang Soo Kim, Nam Joong Kim, Sang‐Ho Choi, Jun-Hee Woo, Jin-Won Chung, Tae Hyong Kim, Sang‐Oh Lee, Mi‐Na Kim, Eun Ju Choo and Baek-Nam Kim. Their work appears in journals such as Microbial Drug Resistance, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Chemotherapy and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.